Want to see HK:0401 full AI Analyst Report?
0401 Stock Chart & Stats
HK$0.09
>-HK$0.01(-5.66%)
At close: 4:00 PM EST
HK$0.09
>-HK$0.01(-5.66%)
Day’s Range― - ―
52-Week RangeHK$0.05 - HK$0.21
Previous CloseN/A
Volume1.34M
Average Volume (3M)589.99K
Market Cap
HK$134.31M
Enterprise ValueHK$59.94
Total Cash (Recent Filing)HK$33.03M
Total Debt (Recent Filing)HK$12.21M
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Nov 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding1,128,615,700
10 Day Avg. Volume1,113,336
30 Day Avg. Volume589,992
Financial Highlights & Ratios
PEG Ratio-0.54
Price to Book (P/B)1.08
Price to Sales (P/S)0.55
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative LeverageA low debt-to-equity (~0.18) provides durable financial flexibility: it reduces refinancing risk, lowers fixed financial burden, and preserves capacity to fund operations or opportunistic investments during downturns. This conservative capital structure supports resilience while profitability normalizes.
Improving Free Cash FlowPositive and improving free cash flow despite accounting losses indicates strong cash conversion and working-capital discipline. Durable FCF can fund working capital, modest reinvestment, and debt service without external financing, improving strategic optionality if the trend is sustained.
Stable Gross MarginsA stable low-30% gross margin suggests consistent product-level economics and pricing or sourcing stability in core healthcare distribution. This underlying margin durability provides a base for operating leverage to restore profitability if fixed costs and SG&A are controlled over the medium term.
Bears Say
Negative Operating MarginsSustained negative operating margins mean the core business is not covering operating costs, limiting internal funding for growth and making profitability recovery essential. If operating losses persist, they will erode reserves and impair the company's ability to invest in distribution and product initiatives long term.
Choppy Revenue TrendsIntermittent revenue declines and irregular growth complicate scale and forecasting. Choppy top-line performance makes it harder to achieve consistent operating leverage and maintain supplier/distributor confidence, which can impede durable margin improvement and strategic planning over the next several quarters.
Negative Return On EquityROE of roughly -10% signals capital erosion and earnings volatility, which undermines the company's ability to compound book value. Persistent negative returns reduce attractiveness to investors, constrain access to new capital, and raise the risk that equity value will be diluted or impaired over time.
Wanjia Group Holdings Ltd. News
0401 FAQ
What was Wanjia Group Holdings Ltd.’s price range in the past 12 months?
Wanjia Group Holdings Ltd. lowest stock price was HK$0.05 and its highest was HK$0.21 in the past 12 months.
What is Wanjia Group Holdings Ltd.’s market cap?
Wanjia Group Holdings Ltd.’s market cap is HK$134.31M.
When is Wanjia Group Holdings Ltd.’s upcoming earnings report date?
Wanjia Group Holdings Ltd.’s upcoming earnings report date is Nov 25, 2026 which is in 112 days.
How were Wanjia Group Holdings Ltd.’s earnings last quarter?
Wanjia Group Holdings Ltd. released its earnings results on Jun 29, 2026. The company reported -HK$0.016 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Wanjia Group Holdings Ltd. overvalued?
According to Wall Street analysts Wanjia Group Holdings Ltd.’s price is currently Overvalued.
Does Wanjia Group Holdings Ltd. pay dividends?
Wanjia Group Holdings Ltd. does not currently pay dividends.
What is Wanjia Group Holdings Ltd.’s EPS estimate?
Wanjia Group Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wanjia Group Holdings Ltd. have?
Wanjia Group Holdings Ltd. has 1,128,615,700 shares outstanding.
What happened to Wanjia Group Holdings Ltd.’s price movement after its last earnings report?
Wanjia Group Holdings Ltd. reported an EPS of -HK$0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Wanjia Group Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:0401
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Wanjia Group Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
117.33%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
24.11%
Trailing 12-Months
Company Description
Wanjia Group Holdings Ltd.
Wanjia Group Holdings Limited operates as an investment holding company, primarily engaged in the wholesale and distribution of pharmaceutical products across mainland China and Hong Kong. The firm also offers hemodialysis treatment and associated consultancy services. Its pharmaceutical goods are supplied to a diverse client base within Fujian province, including hospitals, various healthcare institutions, pharmaceutical retail chains, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Established in 2004, the company is headquartered in Kowloon, Hong Kong.
Technical Analysis
China Health Group
―
Sinopharm Group Co
―
IVD Medical Holding Limited
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―